Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
Identifieur interne : 001665 ( Main/Exploration ); précédent : 001664; suivant : 001666Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
Auteurs : Marinus Van Hulst [Pays-Bas] ; Kwamena W C. Sagoe ; Jacobien E. Vermande ; Ido P. Van Der Schaaf ; Willem P A. Van Der Tuuk Adriani ; Kwasi Torpey ; Justina Ansah ; Julius A A. Mingle ; Cees Th Smit Sibinga ; Maarten J. PostmaSource :
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [ 1524-4733 ]
Descripteurs français
- KwdFr :
- Anticorps anti-VIH (sang), Anticorps anti-VIH (économie), Coûts des soins de santé, Donneurs de sang, Dépenses de santé, Dépistage systématique (économie), Ghana (épidémiologie), Humains, Infections à VIH (), Infections à VIH (transmission), Infections à VIH (économie), Infections à VIH (épidémiologie), Pays en voie de développement, Protéine de capside p24 du VIH (analyse), Protéine de capside p24 du VIH (économie), Prévalence, Transfusion sanguine (normes).
- MESH :
- analyse : Protéine de capside p24 du VIH.
- normes : Transfusion sanguine.
- sang : Anticorps anti-VIH.
- économie : Anticorps anti-VIH, Dépistage systématique, Infections à VIH, Protéine de capside p24 du VIH.
- épidémiologie : Ghana, Infections à VIH.
- Coûts des soins de santé, Donneurs de sang, Dépenses de santé, Humains, Infections à VIH, Pays en voie de développement, Prévalence.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Blood Donors, Blood Transfusion (standards), Developing Countries, Ghana (epidemiology), HIV Antibodies (blood), HIV Antibodies (economics), HIV Core Protein p24 (analysis), HIV Core Protein p24 (economics), HIV Infections (economics), HIV Infections (epidemiology), HIV Infections (prevention & control), HIV Infections (transmission), Health Care Costs, Health Expenditures, Humans, Mass Screening (economics), Prevalence.
- MESH :
- chemical , analysis : HIV Core Protein p24.
- chemical , blood : HIV Antibodies.
- chemical , economics : HIV Antibodies, HIV Core Protein p24.
- geographic , epidemiology : Ghana.
- economics : HIV Infections, Mass Screening.
- epidemiology : HIV Infections.
- prevention & control : HIV Infections.
- standards : Blood Transfusion.
- transmission : HIV Infections.
- Blood Donors, Developing Countries, Health Care Costs, Health Expenditures, Humans, Prevalence.
Abstract
Areas with high HIV-incidence rates compared to the developed world may benefit from additional testing in blood banks and may show more favorable cost-effectiveness ratios. We evaluated the cost-effectiveness of adding p24 antigen, mini pool nucleic acid amplification testing (MP-NAT), or individual donation NAT (ID-NAT) to the HIV-antibody screening at the Korle Bu Teaching Hospital (Accra, Ghana), where currently only HIV-antibody screening is undertaken.
DOI: 10.1111/j.1524-4733.2008.00337.x
PubMed: 18489518
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000205
- to stream PubMed, to step Curation: 000205
- to stream PubMed, to step Checkpoint: 000205
- to stream Ncbi, to step Merge: 000287
- to stream Ncbi, to step Curation: 000287
- to stream Ncbi, to step Checkpoint: 000287
- to stream Main, to step Merge: 001801
- to stream Main, to step Curation: 001665
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).</title><author><name sortKey="Van Hulst, Marinus" sort="Van Hulst, Marinus" uniqKey="Van Hulst M" first="Marinus" last="Van Hulst">Marinus Van Hulst</name><affiliation wicri:level="4"><nlm:affiliation>Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands. m.van.hulst@rug.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Groningen Research Institute of Pharmacy, University of Groningen, Groningen</wicri:regionArea><placeName><settlement type="city">Groningue</settlement><region nuts="2" type="province">Groningue (province)</region></placeName><orgName type="university">Université de Groningue</orgName></affiliation></author><author><name sortKey="Sagoe, Kwamena W C" sort="Sagoe, Kwamena W C" uniqKey="Sagoe K" first="Kwamena W C" last="Sagoe">Kwamena W C. Sagoe</name></author><author><name sortKey="Vermande, Jacobien E" sort="Vermande, Jacobien E" uniqKey="Vermande J" first="Jacobien E" last="Vermande">Jacobien E. Vermande</name></author><author><name sortKey="Van Der Schaaf, Ido P" sort="Van Der Schaaf, Ido P" uniqKey="Van Der Schaaf I" first="Ido P" last="Van Der Schaaf">Ido P. Van Der Schaaf</name></author><author><name sortKey="Van Der Tuuk Adriani, Willem P A" sort="Van Der Tuuk Adriani, Willem P A" uniqKey="Van Der Tuuk Adriani W" first="Willem P A" last="Van Der Tuuk Adriani">Willem P A. Van Der Tuuk Adriani</name></author><author><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name></author><author><name sortKey="Ansah, Justina" sort="Ansah, Justina" uniqKey="Ansah J" first="Justina" last="Ansah">Justina Ansah</name></author><author><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name></author><author><name sortKey="Smit Sibinga, Cees Th" sort="Smit Sibinga, Cees Th" uniqKey="Smit Sibinga C" first="Cees Th" last="Smit Sibinga">Cees Th Smit Sibinga</name></author><author><name sortKey="Postma, Maarten J" sort="Postma, Maarten J" uniqKey="Postma M" first="Maarten J" last="Postma">Maarten J. Postma</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2008 Sep-Oct</MedlineDate></PubDate></date><idno type="RBID">pubmed:18489518</idno><idno type="pmid">18489518</idno><idno type="doi">10.1111/j.1524-4733.2008.00337.x</idno><idno type="wicri:Area/PubMed/Corpus">000205</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000205</idno><idno type="wicri:Area/PubMed/Curation">000205</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000205</idno><idno type="wicri:Area/PubMed/Checkpoint">000205</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000205</idno><idno type="wicri:Area/Ncbi/Merge">000287</idno><idno type="wicri:Area/Ncbi/Curation">000287</idno><idno type="wicri:Area/Ncbi/Checkpoint">000287</idno><idno type="wicri:Area/Main/Merge">001801</idno><idno type="wicri:Area/Main/Curation">001665</idno><idno type="wicri:Area/Main/Exploration">001665</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).</title><author><name sortKey="Van Hulst, Marinus" sort="Van Hulst, Marinus" uniqKey="Van Hulst M" first="Marinus" last="Van Hulst">Marinus Van Hulst</name><affiliation wicri:level="4"><nlm:affiliation>Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands. m.van.hulst@rug.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Groningen Research Institute of Pharmacy, University of Groningen, Groningen</wicri:regionArea><placeName><settlement type="city">Groningue</settlement><region nuts="2" type="province">Groningue (province)</region></placeName><orgName type="university">Université de Groningue</orgName></affiliation></author><author><name sortKey="Sagoe, Kwamena W C" sort="Sagoe, Kwamena W C" uniqKey="Sagoe K" first="Kwamena W C" last="Sagoe">Kwamena W C. Sagoe</name></author><author><name sortKey="Vermande, Jacobien E" sort="Vermande, Jacobien E" uniqKey="Vermande J" first="Jacobien E" last="Vermande">Jacobien E. Vermande</name></author><author><name sortKey="Van Der Schaaf, Ido P" sort="Van Der Schaaf, Ido P" uniqKey="Van Der Schaaf I" first="Ido P" last="Van Der Schaaf">Ido P. Van Der Schaaf</name></author><author><name sortKey="Van Der Tuuk Adriani, Willem P A" sort="Van Der Tuuk Adriani, Willem P A" uniqKey="Van Der Tuuk Adriani W" first="Willem P A" last="Van Der Tuuk Adriani">Willem P A. Van Der Tuuk Adriani</name></author><author><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name></author><author><name sortKey="Ansah, Justina" sort="Ansah, Justina" uniqKey="Ansah J" first="Justina" last="Ansah">Justina Ansah</name></author><author><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name></author><author><name sortKey="Smit Sibinga, Cees Th" sort="Smit Sibinga, Cees Th" uniqKey="Smit Sibinga C" first="Cees Th" last="Smit Sibinga">Cees Th Smit Sibinga</name></author><author><name sortKey="Postma, Maarten J" sort="Postma, Maarten J" uniqKey="Postma M" first="Maarten J" last="Postma">Maarten J. Postma</name></author></analytic><series><title level="j">Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</title><idno type="eISSN">1524-4733</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Donors</term><term>Blood Transfusion (standards)</term><term>Developing Countries</term><term>Ghana (epidemiology)</term><term>HIV Antibodies (blood)</term><term>HIV Antibodies (economics)</term><term>HIV Core Protein p24 (analysis)</term><term>HIV Core Protein p24 (economics)</term><term>HIV Infections (economics)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (prevention & control)</term><term>HIV Infections (transmission)</term><term>Health Care Costs</term><term>Health Expenditures</term><term>Humans</term><term>Mass Screening (economics)</term><term>Prevalence</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps anti-VIH (sang)</term><term>Anticorps anti-VIH (économie)</term><term>Coûts des soins de santé</term><term>Donneurs de sang</term><term>Dépenses de santé</term><term>Dépistage systématique (économie)</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (transmission)</term><term>Infections à VIH (économie)</term><term>Infections à VIH (épidémiologie)</term><term>Pays en voie de développement</term><term>Protéine de capside p24 du VIH (analyse)</term><term>Protéine de capside p24 du VIH (économie)</term><term>Prévalence</term><term>Transfusion sanguine (normes)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>HIV Core Protein p24</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term></keywords><keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>HIV Antibodies</term><term>HIV Core Protein p24</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Protéine de capside p24 du VIH</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>HIV Infections</term><term>Mass Screening</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Transfusion sanguine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-VIH</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Blood Transfusion</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Anticorps anti-VIH</term><term>Dépistage systématique</term><term>Infections à VIH</term><term>Protéine de capside p24 du VIH</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blood Donors</term><term>Developing Countries</term><term>Health Care Costs</term><term>Health Expenditures</term><term>Humans</term><term>Prevalence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Coûts des soins de santé</term><term>Donneurs de sang</term><term>Dépenses de santé</term><term>Humains</term><term>Infections à VIH</term><term>Pays en voie de développement</term><term>Prévalence</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Areas with high HIV-incidence rates compared to the developed world may benefit from additional testing in blood banks and may show more favorable cost-effectiveness ratios. We evaluated the cost-effectiveness of adding p24 antigen, mini pool nucleic acid amplification testing (MP-NAT), or individual donation NAT (ID-NAT) to the HIV-antibody screening at the Korle Bu Teaching Hospital (Accra, Ghana), where currently only HIV-antibody screening is undertaken.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li></country><region><li>Groningue (province)</li></region><settlement><li>Groningue</li></settlement><orgName><li>Université de Groningue</li></orgName></list><tree><noCountry><name sortKey="Ansah, Justina" sort="Ansah, Justina" uniqKey="Ansah J" first="Justina" last="Ansah">Justina Ansah</name><name sortKey="Mingle, Julius A A" sort="Mingle, Julius A A" uniqKey="Mingle J" first="Julius A A" last="Mingle">Julius A A. Mingle</name><name sortKey="Postma, Maarten J" sort="Postma, Maarten J" uniqKey="Postma M" first="Maarten J" last="Postma">Maarten J. Postma</name><name sortKey="Sagoe, Kwamena W C" sort="Sagoe, Kwamena W C" uniqKey="Sagoe K" first="Kwamena W C" last="Sagoe">Kwamena W C. Sagoe</name><name sortKey="Smit Sibinga, Cees Th" sort="Smit Sibinga, Cees Th" uniqKey="Smit Sibinga C" first="Cees Th" last="Smit Sibinga">Cees Th Smit Sibinga</name><name sortKey="Torpey, Kwasi" sort="Torpey, Kwasi" uniqKey="Torpey K" first="Kwasi" last="Torpey">Kwasi Torpey</name><name sortKey="Van Der Schaaf, Ido P" sort="Van Der Schaaf, Ido P" uniqKey="Van Der Schaaf I" first="Ido P" last="Van Der Schaaf">Ido P. Van Der Schaaf</name><name sortKey="Van Der Tuuk Adriani, Willem P A" sort="Van Der Tuuk Adriani, Willem P A" uniqKey="Van Der Tuuk Adriani W" first="Willem P A" last="Van Der Tuuk Adriani">Willem P A. Van Der Tuuk Adriani</name><name sortKey="Vermande, Jacobien E" sort="Vermande, Jacobien E" uniqKey="Vermande J" first="Jacobien E" last="Vermande">Jacobien E. Vermande</name></noCountry><country name="Pays-Bas"><region name="Groningue (province)"><name sortKey="Van Hulst, Marinus" sort="Van Hulst, Marinus" uniqKey="Van Hulst M" first="Marinus" last="Van Hulst">Marinus Van Hulst</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001665 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001665 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18489518
|texte= Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18489518" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |